Neuropeptide Y and osteoblast differentiation – the balance between the neuro‐osteogenic network and local control
暂无分享,去创建一个
Estrela Neto | Meriem Lamghari | M. Sousa | M. Lamghari | E. Neto | Filipa Franquinho | Márcia A Liz | Ana F Nunes | Mónica M Sousa | M. Liz | F. Franquinho | A. Nunes
[1] P. Baldock,et al. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] C. Östenson,et al. Bone and joint neuropathy in rats with type-2 diabetes , 2004, Regulatory Peptides.
[3] R. Jilka,et al. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. , 2005, Endocrinology.
[4] H. Herzog,et al. Inhibitory effects of central neuropeptide Y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones , 2001, Peptides.
[5] R. Palmiter,et al. Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.
[6] R. Pacifici. Editorial: Cytokines, Estrogen, and Postmenopausal Osteoporosis-The Second Decade. , 1998, Endocrinology.
[7] M. Myers,et al. Molecular and neural mediators of leptin action , 2008, Physiology & Behavior.
[8] R. Turner,et al. Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats , 1991, Neuroscience.
[9] R. Mains,et al. The biosynthesis of neuropeptides: peptide alpha-amidation. , 1992, Annual review of neuroscience.
[10] S. Prigge,et al. New insights into copper monooxygenases and peptide amidation: structure, mechanism and function , 2000, Cellular and Molecular Life Sciences CMLS.
[11] Takao Shimizu,et al. Identification of Two Isoforms of Mouse Neuropeptide Y-Y1 Receptor Generated by Alternative Splicing , 1995, The Journal of Biological Chemistry.
[12] M. Fitzgerald,et al. Development of peripheral hindlimb and central spinal cord innervation by subpopulations of dorsal root ganglion cells in the embryonic rat , 2000, The Journal of comparative neurology.
[13] R. Pacifici. Cytokines, estrogen, and postmenopausal osteoporosis--the second decade. , 1998, Endocrinology.
[14] J. Eisman,et al. Greater Bone Formation of Y2 Knockout Mice Is Associated with Increased Osteoprogenitor Numbers and Altered Y1 Receptor Expression* , 2007, Journal of Biological Chemistry.
[15] E. Theodorsson,et al. Extraction and quantitation of neuropeptides in bone by radioimmunoassay , 1994, Regulatory Peptides.
[16] M. Sousa,et al. Neuropeptide Y expression and function during osteoblast differentiation – insights from transthyretin knockout mice , 2010, The FEBS journal.
[17] T. O'donohue,et al. The anatomy of neuropeptide-y-containing neurons in rat brain , 1985, Neuroscience.
[18] T. J. Thurston. Distribution of nerves in long bones as shown by silver impregnation. , 1982, Journal of anatomy.
[19] P. Alberius,et al. Adrenergic innervation of the calvarium of the neonatal rat , 2004, Anatomy and Embryology.
[20] V. Mutt,et al. Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide , 1982, Nature.
[21] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.
[22] Takao Shimizu,et al. Identification of Two Isoforms of Mouse Neuropeptide YY 1 Receptor Generated by Alternative Splicing ISOLATION , 1995 .
[23] C. Schwarzer,et al. Synergistic Effects of Y2 and Y4 Receptors on Adiposity and Bone Mass Revealed in Double Knockout Mice , 2003, Molecular and Cellular Biology.
[24] M. Schultzberg,et al. Neuropeptide Y, Tyrosine Hydroxylase and Vasoactive Intestinal Polypeptide‐Immunoreactive Nerve Fibers in the Vertebral Bodies, Discs, Dura Mater, and Spinal Ligaments of the Rat Lumbar Spine , 1993, Spine.
[25] A. Bjurholm. Neuroendocrine peptides in bone , 2004, International Orthopaedics.
[26] Arndt F Schilling,et al. Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.
[27] A. Gundlach,et al. Expression of galanin and galanin receptor-1 in normal bone and during fracture repair in the rat. , 2003, Bone.
[28] J. Eisman,et al. Critical Interplay Between Neuropeptide Y and Sex Steroid Pathways in Bone and Adipose Tissue Homeostasis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] R. Burstein,et al. Sensory innervation of the calvarial bones of the mouse , 2009, The Journal of comparative neurology.
[30] A. Zengin,et al. Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat , 2010, Trends in Endocrinology & Metabolism.
[31] D. Adriaensen,et al. Development of sensory innervation in rat tibia: co‐localization of CGRP and substance P with growth‐associated protein 43 (GAP‐43) , 2005, Journal of anatomy.
[32] L. Terenius,et al. Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. , 1988, Journal of the autonomic nervous system.
[33] S. Takeda,et al. Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass. , 2003, Endocrinology.
[34] M. Kneissel,et al. SOST is a target gene for PTH in bone. , 2005, Bone.
[35] M. Bouxsein,et al. Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes , 2008, PloS one.
[36] Xi Jiang,et al. Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity , 2009, Journal of cellular biochemistry.
[37] M. Sherman. The Nerves of Bone , 1963 .
[38] T. Nagatsu,et al. Expression of mRNAs for neuropeptide receptors and β-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells , 1997, Neuroscience Letters.
[39] S. Allison,et al. The control of bone remodeling by neuropeptide Y receptors , 2007, Peptides.
[40] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[41] J. Eisman,et al. Neuropeptide Y Knockout Mice Reveal a Central Role of NPY in the Coordination of Bone Mass to Body Weight , 2009, PloS one.
[42] Kevin B. Jones,et al. Bone and brain: a review of neural, hormonal, and musculoskeletal connections. , 2004, The Iowa orthopaedic journal.
[43] F. Pralong,et al. Neuropeptide Y: the universal soldier , 2003, Cellular and Molecular Life Sciences CMLS.
[44] A. Kuntz,et al. Innervation of the bone marrow , 1945, The Journal of comparative neurology.
[45] L. Kruger,et al. Calcitonin‐gene‐related‐peptide‐immunoreactive innervation of the rat head with emphasis on specialized sensory structures , 1989, The Journal of comparative neurology.
[46] A. Sainsbury,et al. Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue , 1996, Diabetologia.
[47] M. Schultzberg,et al. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR‐106–01, ROS 17/2.8, MC3T3‐E1, and Saos‐2) and primary bone cells , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[48] Minqi Li,et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. , 2007, Cell metabolism.
[49] Thurston Tj. Distribution of nerves in long bones as shown by silver impregnation. , 1982 .
[50] Matthew R Allen,et al. Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin* , 2008, Journal of Biological Chemistry.
[51] T. Nagao,et al. Pancreatic polypeptide is secreted from and controls differentiation through its specific receptors in osteoblastic MC3T3-E1 cells , 2008, Peptides.
[52] M. Sousa,et al. NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors , 2009, Journal of cellular biochemistry.
[53] G. Thomas,et al. Hypothalamic Y2 receptors regulate bone formation. , 2002, The Journal of clinical investigation.
[54] M. Ghatei,et al. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. , 1993, Endocrinology.
[55] W. Calvo,et al. On the development of bone marrow innervation in new-born rats as studied with silver impregnation and electron microscopy. , 1969, The American journal of anatomy.
[56] J. Bue-Valleskey,et al. The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.
[57] S. Woods,et al. Estradiol-Dependent Decrease in the Orexigenic Potency of Ghrelin in Female Rats , 2007, Diabetes.
[58] M. Sousa,et al. Transthyretin knockouts are a new mouse model for increased neuropeptide Y , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[59] C. Bünger,et al. Vasoconstrictive action of neuropeptide Y in bone. The porcine tibia perfused in vivo. , 1994, Acta orthopaedica Scandinavica.
[60] U. Lerner. The Role of Skeletal Nerve Fibers in Bone Metabolism , 2000 .
[61] Patricia Ducy,et al. Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.
[62] Wei Yao,et al. Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. , 2008, Bone.
[63] S. Allison,et al. Hypothalamic Control of Bone Formation: Distinct Actions of Leptin and Y2 Receptor Pathways , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[64] J. Eisman,et al. Hypothalamic Regulation of Cortical Bone Mass: Opposing Activity of Y2 Receptor and Leptin Pathways , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[65] J. Eisman,et al. Novel Role of Y1 Receptors in the Coordinated Regulation of Bone and Energy Homeostasis* , 2007, Journal of Biological Chemistry.
[66] G. Karsenty,et al. The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.
[67] Malcolm R. Miller,et al. Observations on the innervation of human long bones , 1963 .
[68] Rene Devos,et al. Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.
[69] C. Schwarzer,et al. Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. , 2002, Diabetes.
[70] A. Kreicbergs,et al. The development of autonomic innervation in bone and joints of the rat. , 1996, Journal of the autonomic nervous system.
[71] D. Larhammar,et al. Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[72] R. Elde,et al. Distribution of CGRP-, VIP-, DβH-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat , 1991, Cell and Tissue Research.
[73] P. Mantyh,et al. Peripheral patterns of calcitonin‐gene‐related peptide general somatic sensory innervation: Cutaneous and deep terminations , 1989, The Journal of comparative neurology.
[74] J. Eisman,et al. Conditional Deletion of Hypothalamic Y2 Receptors Reverts Gonadectomy-induced Bone Loss in Adult Mice* , 2006, Journal of Biological Chemistry.